Published in Histopathology on August 01, 2006
Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00
Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers. Virchows Arch (2009) 1.67
A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol (2011) 1.16
Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch (2007) 1.15
Serrated polyps of the colon and rectum (hyperplastic polyps, sessile serrated adenomas, traditional serrated adenomas, and mixed polyps)-proposal for diagnostic criteria. Virchows Arch (2010) 1.14
Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. Am J Surg Pathol (2009) 1.13
Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype. Histopathology (2008) 1.12
Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. Mol Cancer (2006) 1.08
Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Patholog Res Int (2011) 1.01
Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol (2012) 1.00
Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations. Virchows Arch (2011) 1.00
Serrated neoplasia of the colorectum. World J Gastroenterol (2007) 0.97
Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol (2012) 0.97
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context. Mol Cancer (2008) 0.95
Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer (2008) 0.94
Distinct patterns of DNA methylation in conventional adenomas involving the right and left colon. Mod Pathol (2013) 0.92
Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Arch (2009) 0.90
Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6. Curr Oncol (2007) 0.90
DNA methylation changes in ex-adenoma carcinoma of the large intestine. Virchows Arch (2010) 0.89
Sessile serrated adenoma shares similar genetic and epigenetic features with microsatellite unstable colon cancer in a location-dependent manner. Exp Ther Med (2011) 0.89
Serrated polyps detected during screening colonoscopies. Contemp Oncol (Pozn) (2014) 0.86
Management of serrated adenomas and hyperplastic polyps. Clin Colon Rectal Surg (2008) 0.86
Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions. Virchows Arch (2011) 0.86
B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P. Br J Cancer (2014) 0.84
Colonic lipoma covered by hyperplastic epithelium: Case report. World J Clin Cases (2013) 0.84
Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation. PLoS Genet (2013) 0.84
Toward a Molecular Classification of Colorectal Cancer: The Role of MGMT. Front Oncol (2013) 0.84
Serrated polyps of right colon: guilty or innocent? Ann Gastroenterol (2013) 0.84
Sessile serrated polyps of the colorectum are rare in patients with Lynch syndrome and in familial colorectal cancer families. Fam Cancer (2007) 0.83
Externalization of saw-tooth architecture in small serrated polyps implies the presence of methylation of IGFBP7. Dig Dis Sci (2011) 0.83
Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis. PLoS One (2012) 0.82
Differential expression of p53 and p504s in hyperplastic polyp, sessile serrated adenoma and traditional serrated adenoma. Int J Colorectal Dis (2010) 0.81
Split-Dose Polyethylene Glycol Is Superior to Single Dose for Colonoscopy Preparation: Results of a Randomized Controlled Trial. Can J Gastroenterol Hepatol (2016) 0.81
Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions. Oncotarget (2016) 0.81
HLA Class I Expressions on Peripheral Blood Mononuclear Cells in Colorectal Cancer Patients. Chin J Cancer Res (2012) 0.80
IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. World J Gastroenterol (2014) 0.80
Defined morphological criteria allow reliable diagnosis of colorectal serrated polyps and predict polyp genetics. Virchows Arch (2014) 0.79
Genetic characteristics of mitochondrial DNA was associated with colorectal carcinogenesis and its prognosis. PLoS One (2015) 0.79
Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlation. J Pathol Clin Res (2016) 0.78
Identification of differential gene expressions in colorectal cancer and polyp by cDNA microarray. World J Gastroenterol (2012) 0.78
Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial. Clin Gastroenterol Hepatol (2008) 0.78
Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1. Cancers (Basel) (2010) 0.77
Clinical implications of BRAF mutation test in colorectal cancer. Gastroenterol Hepatol Bed Bench (2013) 0.76
Hyperplastic polyps are innocuous lesions in hereditary nonpolyposis colorectal cancers. Int J Surg Oncol (2011) 0.76
From traditional serrated adenoma to tubulovillous adenoma and beyond. World J Gastrointest Oncol (2016) 0.75
Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities. Int J Mol Med (2016) 0.75
Histopathological and genetic differences between polypoid and non-polypoid submucosal colorectal carcinoma. World J Gastroenterol (2007) 0.75
What influences preneoplastic colorectal lesion recurrence? Oncotarget (2016) 0.75
PIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation. Int J Med Sci (2015) 0.75
Molecular features of colorectal polyps presenting Kudo's type II mucosal crypt pattern: are they based on the same mechanism of tumorigenesis? Endosc Int Open (2014) 0.75
Oncogene Mutations in Colorectal Polyps Identified in the Norwegian Colorectal Cancer Prevention (NORCCAP) Screening Study. Clin Med Insights Pathol (2016) 0.75
Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article. Medicine (Baltimore) (2016) 0.75
Invasive adenocarcinoma arising from a mixed hyperplastic/adenomatous polyp and synchronous transverse colon cancer. World J Surg Oncol (2013) 0.75
Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer. Int J Colorectal Dis (2011) 0.75
Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach. Mod Pathol (2017) 0.75
KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia. PLoS One (2017) 0.75
Prospective evaluation of a simplified narrowband imaging scoring system for a differential diagnosis of colorectal lesions. Surg Endosc (2015) 0.75
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
The evolution of cancer of the colon and rectum. Cancer (1975) 9.05
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst (2005) 5.22
Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med (1992) 5.18
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol (1990) 3.89
Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol (2003) 3.59
Serrated adenomatous polyposis in humans. Gastroenterology (1996) 3.30
Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol (2005) 3.29
Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis. J Pathol (2001) 3.24
Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol (2003) 3.05
Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res (2000) 2.99
Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol (1982) 2.89
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res (2000) 2.79
DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol (1999) 2.78
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Emerging concepts in colorectal neoplasia. Gastroenterology (2002) 2.44
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology (2001) 2.30
BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res (2003) 2.27
Risk of colorectal cancer in adenoma-bearing individuals within a defined population. Int J Cancer (1986) 2.22
Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol (2005) 2.08
Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol (2005) 2.03
Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res (2001) 1.97
Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res (2001) 1.87
APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73
BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol (2004) 1.71
Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70
High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut (1997) 1.61
Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol (2002) 1.56
Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol (2004) 1.50
Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology (2005) 1.43
Adenomas of the colon: overexpression of p53 protein and risk factors. Endoscopy (1998) 1.41
Molecular characteristics of serrated adenomas of the colorectum. Gut (2002) 1.31
Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol (2004) 1.30
Relation between metaplastic polyp and carcinoma of the colorectum. Lancet (1983) 1.29
Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res (2004) 1.16
Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol (2005) 1.13
Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol (1998) 1.10
Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol (2002) 1.08
BRAF mutation associated with dysregulation of apoptosis in human colorectal neoplasms. Int J Cancer (2005) 1.04
Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol (2002) 1.04
Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology (2001) 1.00
K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res (1997) 0.99
Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol (2005) 0.95
Involvement of APC and K-ras mutation in non-polypoid colorectal tumorigenesis. Br J Cancer (2000) 0.94
Genetic alterations in serrated adenomas: comparison to conventional adenomas and hyperplastic polyps. Hum Pathol (2002) 0.91
Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC->AT transition mutations in a population exposed to methylating agents. Carcinogenesis (2004) 0.85
Cell kinetics, p53 and bcl-2 expression, and c-Ki-ras mutations in flat-elevated tubulovillous adenomas and adenocarcinomas of the colorectum: comparison with polypoid lesions. Scand J Gastroenterol (1999) 0.85
Villous tumor of the colon and rectum with special reference to roles of p53 and bcl-2 in adenoma-carcinoma sequence. Pathol Int (1999) 0.84
Proliferation kinetics and apoptosis of serrated adenoma of the colorectum. Pathol Int (2003) 0.83
Tracing origin of serrated adenomas with BRAF and KRAS mutations. Virchows Arch (2005) 0.81
Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients. Mol Carcinog (2003) 0.80
Immunohistochemical demonstration of p53 protein in colorectal adenomas and adenocarcinomas. Reliable application of the heat-induced antigen retrieval method to formalin-fixed, paraffin-embedded material. Pathol Int (1995) 0.77
'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res (1991) 19.71
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology (2007) 7.16
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science (1997) 6.82
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature (2007) 4.99
A combined PET/CT scanner for clinical oncology. J Nucl Med (2000) 4.99
T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity (2001) 4.62
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Babies sleeping with parents: case-control study of factors influencing the risk of the sudden infant death syndrome. CESDI SUDI research group. BMJ (1999) 3.76
Improving the repeat prescribing process in a busy general practice. A study using continuous quality improvement methodology. Qual Health Care (1999) 3.61
Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry (2007) 3.60
Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology (2001) 3.52
What do we know about how to do audit and feedback? Pitfalls in applying evidence from a systematic review. BMC Health Serv Res (2005) 3.51
The Uterine Mucosa in Menstruation and Pregnancy; the Action of the Chorionic Cells and the Function of the Decidua: Structure of the Uterine Mucosa and the Cause of the Opening-up of the Vessels during Menstruation. Proc R Soc Med (1911) 3.46
Randomised trial comparing a policy of early with selective amniotomy in uncomplicated labour at term. Br J Obstet Gynaecol (1997) 3.37
Adenocarcinoma of colon differentiating as dome epithelium of gut-associated lymphoid tissue. Histopathology (2000) 3.36
ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem (1999) 3.25
The AEtiology of Eclampsia and Albuminuria and their Relation to Accidental Haemorrhage: (An Anatomical and Experimental Investigation.). Proc R Soc Med (1914) 3.13
Morphology of sporadic colorectal cancer with DNA replication errors. Gut (1998) 3.11
Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol (2001) 3.07
Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics (2001) 3.02
Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest (1981) 2.97
Incidence and consequences of falls due to stroke: a systematic inquiry. BMJ (1995) 2.94
DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol (1999) 2.78
Who is speaking for children and adolescents and for their health at the policy level? BMJ (2000) 2.75
Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed (1999) 2.73
The mind's scalpel in surgical education: a randomised controlled trial of mental imagery. BJOG (2012) 2.71
Pharmacokinetic and pharmacodynamic studies with long-acting propranolol. Br J Clin Pharmacol (1978) 2.68
A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med (1997) 2.66
Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish Effect'. J Public Health (Oxf) (2005) 2.58
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer (2012) 2.46
Analysis of trends in deaths from accidental drug poisoning in teenagers, 1985-95. BMJ (1997) 2.44
A family of putative potassium channel genes in Drosophila. Science (1989) 2.38
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis (2000) 2.35
K+ current diversity is produced by an extended gene family conserved in Drosophila and mouse. Science (1990) 2.33
Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol (2001) 2.29
Unexplained hepatitis C virus antibody seroconversion in established blood donors. Transfusion (1996) 2.26
An essential 'set' of K+ channels conserved in flies, mice and humans. Trends Neurosci (1992) 2.19
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med (1997) 2.15
Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation (2009) 2.15
Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol (2010) 2.10
Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol (2001) 2.10
Future directions for geriatric medicine. Geriatricians must move with their patients into the community. BMJ (2000) 2.10
Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun (1988) 2.10
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
A clinical neurological, neurophysiological, and neuropsychological study of sheep farmers and dippers exposed to organophosphate pesticides. Occup Environ Med (2002) 2.04
An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers. Occup Environ Med (2001) 2.03
THE COMPLETE AMINO ACID SEQUENCE OF THE PROTEIN OF TOBACCO MOSAIC VIRUS. Proc Natl Acad Sci U S A (1960) 2.02
Decision-making in rectal surgery. Colorectal Dis (2014) 2.01
Biosynthesis of bacterial lipopolysaccharide. V. Lipid-linked intermediates in the biosynthesis of the O-antigen groups of Salmonella typhimurium. Proc Natl Acad Sci U S A (1965) 2.00
Release of a chimeric protein into the medium from Escherichia coli using the C-terminal secretion signal of haemolysin. EMBO J (1987) 1.99
Absence of activating mutations in the GnRH receptor gene in human pituitary gonadotroph adenomas. Eur J Endocrinol (1998) 1.99
Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. Inhal Toxicol (2000) 1.99
Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol (1999) 1.98
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer (2010) 1.96
Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut (2000) 1.95
Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax (1990) 1.95
Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer. Br J Surg (2000) 1.93
Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev (2011) 1.93
Human herpesviruses in the cornea. Br J Ophthalmol (2000) 1.90
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90
A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol (1991) 1.88
Influencing sceptical staff to become supporters of service improvement: a qualitative study of doctors' and managers' views. Qual Saf Health Care (2004) 1.87
Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res (2001) 1.87
Diffusion of standards of care for cancer pain. CMAJ (1995) 1.86
Sequence-tagged connectors: a sequence approach to mapping and scanning the human genome. Proc Natl Acad Sci U S A (1999) 1.85
Mouse models in the study of the Ets family of transcription factors. Oncogene (2000) 1.84
mShal, a subfamily of A-type K+ channel cloned from mammalian brain. Proc Natl Acad Sci U S A (1991) 1.82
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (1986) 1.81
p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol (2010) 1.76
A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med (1973) 1.76
To suspend or not to suspend: a randomised single blind trial of simple trapeziectomy versus trapeziectomy and flexor carpi radialis suspension. J Hand Surg Eur Vol (2007) 1.69
Information provision for stroke patients and their caregivers. Cochrane Database Syst Rev (2008) 1.69
Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc Natl Acad Sci U S A (1999) 1.67
Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer (2002) 1.66
Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam Cancer (2004) 1.66
Growth and function of the embryonic heart depend upon the cardiac-specific L-type calcium channel alpha1 subunit. Dev Cell (2001) 1.65
Epidemiology of flea infestation of ruminants in Libya. Vet Parasitol (2006) 1.64
Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol (1996) 1.63
High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms. J Pathol (2006) 1.62
A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J Virol (1991) 1.62
Evidence databases, the Internet, and general practitioners: the New Zealand story. N Z Med J (2001) 1.62
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology (1997) 1.62
A novel C-terminal signal sequence targets Escherichia coli haemolysin directly to the medium. J Cell Sci Suppl (1989) 1.60
The genetic basis of tuberous sclerosis. Mol Med Today (1998) 1.60
Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging (1996) 1.59
Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol (2001) 1.59
DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer. Gut (2000) 1.58
Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology (2000) 1.57
Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene (2006) 1.56
Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis (1999) 1.55
Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics (1997) 1.55